Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Hims & Hers Health, Inc.CL A(HIMS) | 3,833,381 | 3,326,783 | -506,598 | $34.12M | $51.47M | 48.31% | +$17.35M |
| CG Oncology, Inc.(CGON) | 0 | 692,550 | +692,550 | $0 | $30.40M | 28.54% | +$30.40M |
| Disc Medicine, Inc.(IRON) | 243,513 | 243,513 | 0 | $14.07M | $15.16M | 14.23% | +$1.10M |
| Kinnate Biopharma Inc. | 3,525,957 | 3,525,957 | 0 | $8.36M | $9.38M | 8.80% | +$1.02M |
| 23andMe Holding Co.CL A | 232,200 | 232,200 | 0 | $212.1K | $123.5K | 0.12% | -$88.6K |
| Theseus Pharmaceuticals, Inc. | 4,108,796 | 0 | -4,108,796 | $16.64M | $0 | — | -$16.64M |